PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion

News   Jun 19, 2017

 
PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion
 
 
 

RELATED ARTICLES

Cancer-fighting Cells Get a Boost from Oxygen Starvation Treatment

News

Mountain climbers and endurance athletes are not the only ones to benefit from altitude training – that is, learning to perform well under low-oxygen conditions.

READ MORE

Metabolic Classification of Human Hepatoblastoma Uncovered

News

EPFL scientists have now found metabolic differences between hepatoblastoma subtypes, and identified several biomarkers that can help obtain more accurate subtyping of the disease.

READ MORE

Superior Pathological Diagnosis Using Transparent Tissues

News

In a new study researchers report CUBIC, a technique including a tissue processing that makes human organs transparent, and provides better assessment of lesions for pathological diagnosis.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE